OverviewSuggest Edit

Abbott is a healthcare company specializing in diagnostics, medical devices, nutritionals, and branded generic medicines. It has expertise in glucose monitoring, blood and plasma screening, adult nutrition, pediatric nutrition, remote heart failure monitoring, point of care testing. The company offers a variety of chronic pain devices and heart pumps (LVADs).
TypePublic
Founded1991
HQLake Bluff, US
Websiteabbott.com
Employee Ratings3.5
Culture scoreC+

Latest Updates

Employees (est.) (Dec 2019)107,000(+4%)
Job Openings1,362
Revenue (FY, 2019)$31.9 B(+5%)
Share Price (May 2020)$91.5 (+2%)

Key People/Management at Abbott

Hubert L. Allen

Hubert L. Allen

Executive Vice President, General Counsel and Secretary
Miles White

Miles White

Chairman and Chief Executive Officer
Lisa D. Earnhardt

Lisa D. Earnhardt

Executive Vice President, Medical Devices
John F. Ginascol

John F. Ginascol

Executive Vice President, Core Diagnostics
John M. Capek

John M. Capek

Executive Vice President, Ventures
Andrew H. Lane

Andrew H. Lane

Executive Vice President, Established Pharmaceuticals
Show more

Abbott Office Locations

Abbott has offices in Lake Bluff, Alameda, Lake Forest, Plano and in 122 other locations
Lake Bluff, US (HQ)
100 Abbott Park Rd
Alameda, US
1420 Harbor Bay Pkwy
Lake Forest, US
675 N Field Dr
Plano, US
6901 Preston Rd
Plymouth, US
5050 Nathan Ln N
Santa Clara, US
3200 Lakeside Dr
Show all (144)

Abbott Financials and Metrics

Abbott Revenue

Embed Graph
View revenue for all periods
Abbott's revenue was reported to be $31.90 b in FY, 2019 which is a 4.3% increase from the previous period.
USD

Revenue (Q1, 2020)

7.7b

Gross profit (Q1, 2020)

4.4b

Gross profit margin (Q1, 2020), %

57.5%

Net income (Q1, 2020)

564.0m

EBIT (Q1, 2020)

758.0m

Market capitalization (22-May-2020)

161.8b

Closing stock price (22-May-2020)

91.5

Cash (31-Mar-2020)

3.4b

EV

176.7b
Abbott's current market capitalization is $161.8 b.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

20.9b27.4b30.6b31.9b

Revenue growth, %

2%31%12%4%

Cost of goods sold

9.0b12.3b12.7b13.2b

Gross profit

11.8b15.1b17.9b18.7b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

6.3b6.6b6.8b7.4b7.8b7.7b7.5b8.0b8.1b7.7b

Cost of goods sold

3.0b3.2b2.9b3.1b3.3b3.2b3.2b3.3b3.4b3.3b

Gross profit

3.3b3.5b4.0b4.3b4.5b4.5b4.4b4.7b4.7b4.4b

Gross profit Margin, %

52%52%58%58%58%59%58%59%58%58%
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

18.6b9.4b3.8b3.9b

Accounts Receivable

3.2b5.2b5.2b5.4b

Prepaid Expenses

1.8b1.7b1.6b

Inventories

2.4b3.6b3.8b4.3b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

8.7b9.7b11.0b3.9b3.1b7.4b3.0b3.1b4.1b3.4b

Accounts Receivable

4.5b4.6b4.8b5.4b5.2b5.3b5.3b5.5b5.5b5.3b

Prepaid Expenses

2.0b1.9b1.9b1.7b1.9b1.6b1.7b1.9b1.9b

Inventories

4.0b3.6b3.5b3.8b3.7b3.8b4.1b4.4b4.4b4.6b
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

1.4b477.0m2.4b3.7b

Depreciation and Amortization

1.4b3.0b3.3b3.0b

Inventories

(98.0m)249.0m(514.0m)(593.0m)

Accounts Payable

(652.0m)615.0m747.0m220.0m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

419.0m702.0m1.3b418.0m1.2b1.7b672.0m1.7b2.6b564.0m

Depreciation and Amortization

774.0m1.4b2.2b852.0m1.7b2.5b753.0m1.5b2.3b828.0m

Inventories

(162.0m)(127.0m)39.0m(171.0m)(336.0m)(450.0m)(286.0m)(540.0m)(730.0m)(437.0m)

Cash From Operating Activities

574.0m1.9b3.9b1.1b2.4b4.5b712.0m1.8b3.7b715.0m
USDY, 2020

EV/EBIT

233.1 x

EV/CFO

247.1 x

Financial Leverage

2.2 x
Show all financial metrics

Abbott Operating Metrics

FY, 2016FY, 2017FY, 2018FY, 2019

Manufacturing Sites

100 94 92

New Product Launches

25 25

Products

1.50 k1.50 k1.50 k

Research and Development Centers

12
Show all operating metrics

Abbott Acquisitions / Subsidiaries

Company NameDateDeal Size
Cephea Valve TechnologiesJanuary 16, 2019
AlereAugust 14, 2017$5.30 b
St. Jude MedicalApril 28, 2016$25 b
Kalila MedicalApril 06, 2016
Tendyne Holdings, Inc.July 31, 2015$250 m
VeropharmDecember 12, 2014$305 m
Topera, Inc.October 29, 2014$250 m
CFR PharmaceuticalsMay 15, 2014$2.90 b
IDEV Technologies, Inc.July 15, 2013$310 m
OptiMedicaJuly 15, 2013$400 m
Show more

Abbott Revenue Breakdown

Embed Graph

Abbott revenue breakdown by business segment: 42.2% from Medical Devices, 16.6% from Diagnostics, 15.5% from Established Pharmaceuticals, 25.5% from Nutritionals and 0.2% from Other

Abbott revenue breakdown by geographic segment: 64.3% from International and 35.7% from United States

Abbott Online and Social Media Presence

Embed Graph

Abbott Company Culture

  • Overall Culture

    C+

    67/100

  • CEO Rating

    A-

    74/100

  • Compensation

    B-

    67/100

  • Diversity

    C+

    67/100

Learn more on Comparably

Abbott Blogs

Abbott's TriClip™ Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair

- CE Mark for TriClip represents an important treatment option for people with severe tricuspid regurgitation, a difficult-to-manage heart condition

Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic

-- More than 50% of people with diabetes who have been diagnosed with COVID-19 are hospitalized, according to a report from the Centers for Disease Control and Prevention (CDC)¹

Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes

- The Abbott ID NOW™ COVID-19 test brings rapid testing to the front lines

Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus

- The test will be used on the company's m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.

Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav™ Delivery System for the Company's Portico™ Valve

- New FlexNav™ delivery system improves control and delivery of the Portico™ TAVI valve even in complex clinical cases
Show more

Abbott Frequently Asked Questions

  • When was Abbott founded?

    Abbott was founded in 1991.

  • Who are Abbott key executives?

    Abbott's key executives are Hubert L. Allen, Miles White and Lisa D. Earnhardt.

  • How many employees does Abbott have?

    Abbott has 107,000 employees.

  • What is Abbott revenue?

    Latest Abbott annual revenue is $31.9 b.

  • What is Abbott revenue per employee?

    Latest Abbott revenue per employee is $298.2 k.

  • Who are Abbott competitors?

    Competitors of Abbott include Bio-Rad, Philips and Danaher.

  • Where is Abbott headquarters?

    Abbott headquarters is located at 100 Abbott Park Rd, Lake Bluff.

  • Where are Abbott offices?

    Abbott has offices in Lake Bluff, Alameda, Lake Forest, Plano and in 122 other locations.

  • How many offices does Abbott have?

    Abbott has 144 offices.